No Data
No Data
Cytokinetics New Analysis of Heart Medication Study Shows Beneficial Changes
Cytokinetics Presents Additional Data From SEQUOIA-HCM At The HCMS Scientific Sessions; Says "Overall, 83.8% Of Patients Treated With Aficamten Experienced Favorable Effects In At Least One Of The Five Domains, Compared To 39.3% Of Patients On Placebo"
Express News | Cytokinetics Presents Additional Data From Sequoia-HCM at the Hcms Scientific Sessions
Express News | Cytokinetics Inc - Program to Award Five $20,000 Grants to Patient Advocacy Organizations
Express News | Cytokinetics Announces Call for Proposals for Its Seventh Annual Communications Grant Program
A Quick Look at Today's Ratings for Cytokinetics(CYTK.US), With a Forecast Between $60 to $92
No Data
No Data
章允量 :
103677010 : noted